Search Results 211-220 of 17351 for hba1c

  1. LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma - Mayo Clinic

    Patients with fasting glucose > 120 mg/dL or 6.7 mmol/L, and HbA1c > 8 %. Patient has any of the following mood disorders as judged by the. Investigator or a ...

  2. Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  3. Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer - Mayo Clinic

    mg/dL [7.7 mmol/L], or glycosylated hemoglobin [HbA1c] level of >6.4%). 3. Known intolerance to alpelisib or any of its excipients. 4. Patient is currently ...

  4. A Study to Evaluate Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) - Mayo Clinic

    - Uncontrolled diabetes (HbA1c > 11.0%) at Screen A visit; - Serum albumin < 3 g/dL at Screen A visit; - History of intracranial aneurysms; - Kidney or any ...

  5. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Uncontrolled diabetes defined as hemoglobin A1c (HbA1c) ≥ 8 or fasting blood glucose ≥ 140 mg/dL. Any of the following. History of significant ventricular ...

  6. ALSENLITE: Senolytics for Alzheimer's Disease - Mayo Clinic

    Uncontrolled diabetes (defined as HbA1c > 7% or as per clinical judgment). 27. Gastric bypass/reduction 28. Crohn's disease 29. Myopathies (increased or low ...

  7. A Study to Evaluate the Safety and Effectiveness of Felzartamab in IgA Nephropathy - Mayo Clinic

    Participation eligibility · Glycated hemoglobin (HbA1c) < 8.0% or < 64 mmoL/mol.; · No diabetic retinopathy known; · No peripheral neuropathy known.

  8. After Procedure | Diabetes remission index (DRI) calculator

    What is your HbA1c level range after undergoing the bariatric procedure? < 7%. 7.0-7.9%. 8.0-8.9%. 9%+. Step 7 of 7. What type of surgery did you have? RYGB. SG.

  9. Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States - Mayo Clinic

    Uncontrolled diabetes (HbA1c ≥ 9.0%) within past 24 weeks 17. Kidney function abnormalities including: a. Dialysis b. Baseline epidermal growth factor ...

  10. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have moderate or advanced liver fibrosis - Mayo Clinic

    HbA1c > 10% (> 86 mmol/mol) as measured by the central laboratory at screening. Impaired renal function, defined as eGFR 2x ULN as measured by the central ...